Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
794,754.00 Euro
Request Reference:
ULS São José 51019424
Request Name:
Canacinumab 150 mg pó sol inj FR SC e Ofatumumab 20 mg/0.4 ml sol inj caneta 0.4 ml SC
Phase:
Tendering Phase
State:
Awarded
Description:
Canacinumab 150 mg pó sol inj FR SC e Ofatumumab 20 mg/0.4 ml sol inj caneta 0.4 ml SC
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
C1009 - CANACINUMAB [150 MG; PÓ SOL INJ; FRS]
-
9
(
Months
)
O1036 - OFATUMUMAB [20 MG/0.4 ML; SOL INJ; CANETA]
-
9
(
Months
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Rua José António Serrano 1150-199 Arroios Lisboa PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
3/25/2024 6:26 PM
(UTC 0 hours)
National official publishing date and time (DR):
9/4/2023 6:18 PM
(UTC +1 hour)
Due datetime for receiving replies:
3/27/2024 6:00 PM
(UTC 0 hours)
Financial Settings
Financial Settings
Define Warranties?
Yes
Seriousness of the offer
Compliance
No
Extra-contractual civil liability
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
convite 51019424.pdf
convite 51019424.pdf
Download
Modelo caução.pdf
Modelo caução.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
Vision
1
Título do Lote
C1009 - CANACINUMAB [150 MG; PÓ SOL INJ; FRS]
Preço Base / Valor Estimado
314 754,00
1.1
Bill of Quantities
Esta lista de preços tem requisitos adicionais. Certifique-se de que tudo está completo em cada linha de artigo.
Código
Descrição
Qt
Unidade
C1009
CANACINUMAB [150 MG; PÓ SOL INJ; FRS]
30,000000
FRASCO
Comentários
500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023491/128/0318 | NºAIM:5252457;
Totais
(Os valores mostrados não incluem IVA)
2
Título do Lote
O1036 - OFATUMUMAB [20 MG/0.4 ML; SOL INJ; CANETA]
Preço Base / Valor Estimado
480 000,00
2.1
Bill of Quantities
Esta lista de preços tem requisitos adicionais. Certifique-se de que tudo está completo em cada linha de artigo.
Código
Descrição
Qt
Unidade
O1036
OFATUMUMAB [20 MG/0.4 ML; SOL INJ; CANETA]
400,000000
CANETA
Comentários
500063524 | Novartis Farma - Produtos Farmacêuticos, S.A. | CPA:2023491/128/0347 | NºAIM:5814421;
Totais
(Os valores mostrados não incluem IVA)
Evaluation
Evaluation
Vision
undefinedundefined
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...